메뉴 건너뛰기




Volumn 74, Issue 1, 2006, Pages 777-780

Immunization with persistent attenuated Δlpg2 Leishmania major parasites requires adjuvant to provide protective immunity in C57BL/6 mice

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CPG OLIGODEOXYNUCLEOTIDE; GUANOSINE DIPHOSPHATE MANNOSE; IMMUNOLOGICAL ADJUVANT; LEISHMANIA VACCINE; LIVE VACCINE;

EID: 29644439033     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.74.1.777-780.2006     Document Type: Article
Times cited : (27)

References (13)
  • 1
    • 0027395378 scopus 로고
    • Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: A possible hazard for the host
    • Aebischer, T., S. F. Moody, and E. Handman. 1993. Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect. Immun. 61:220-226.
    • (1993) Infect. Immun. , vol.61 , pp. 220-226
    • Aebischer, T.1    Moody, S.F.2    Handman, E.3
  • 2
    • 0035914841 scopus 로고    scopus 로고
    • The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure
    • Belkaid, Y., K. F. Hoffmann, S. Mendez, S. Kamhawi, M. C. Udey, T. A. Wynn, and D. L. Sacks. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194:1497-1506.
    • (2001) J. Exp. Med. , vol.194 , pp. 1497-1506
    • Belkaid, Y.1    Hoffmann, K.F.2    Mendez, S.3    Kamhawi, S.4    Udey, M.C.5    Wynn, T.A.6    Sacks, D.L.7
  • 3
    • 2242423605 scopus 로고    scopus 로고
    • CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
    • Belkaid, Y., C. A. Piccirillo, S. Mendez, E. M. Shevach, and D. L. Sacks. 2002. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420:502-507.
    • (2002) Nature , vol.420 , pp. 502-507
    • Belkaid, Y.1    Piccirillo, C.A.2    Mendez, S.3    Shevach, E.M.4    Sacks, D.L.5
  • 4
    • 0041322722 scopus 로고    scopus 로고
    • Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous leishmaniasis but maintains its potency and durability
    • Mendez, S., K. Tabbara, Y. Belkaid, S. Bertholet, D. Verthelyi, D. Klinman, R. A. Seder, and D. L. Sacks. 2003. Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous leishmaniasis but maintains its potency and durability. Infect. Immun. 71:5121-5129.
    • (2003) Infect. Immun. , vol.71 , pp. 5121-5129
    • Mendez, S.1    Tabbara, K.2    Belkaid, Y.3    Bertholet, S.4    Verthelyi, D.5    Klinman, D.6    Seder, R.A.7    Sacks, D.L.8
  • 5
    • 0037124332 scopus 로고    scopus 로고
    • Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection
    • Rhee, E. G., S. Mendez, J. A. Shah, C. Y. Wu, J. R. Kirman, T. N. Turon, D. F. Davey, H. Davis, D. M. Klinman, R. N. Coler, D. L. Sacks, and R. A. Seder. 2002. Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection. J. Exp. Med. 195:1565-1573.
    • (2002) J. Exp. Med. , vol.195 , pp. 1565-1573
    • Rhee, E.G.1    Mendez, S.2    Shah, J.A.3    Wu, C.Y.4    Kirman, J.R.5    Turon, T.N.6    Davey, D.F.7    Davis, H.8    Klinman, D.M.9    Coler, R.N.10    Sacks, D.L.11    Seder, R.A.12
  • 7
    • 0036831673 scopus 로고    scopus 로고
    • The immunology of susceptibility and resistance to Leishmania major in mice
    • Sacks, D., and N. Noben-Trauth. 2002. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2:845-858.
    • (2002) Nat. Rev. Immunol. , vol.2 , pp. 845-858
    • Sacks, D.1    Noben-Trauth, N.2
  • 8
    • 0024236111 scopus 로고
    • Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens
    • Scott, P., P. Natovitz, R. L. Coffman, E. Pearce, and A. Sher. 1988. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168:1675-1684.
    • (1988) J. Exp. Med. , vol.168 , pp. 1675-1684
    • Scott, P.1    Natovitz, P.2    Coffman, R.L.3    Pearce, E.4    Sher, A.5
  • 9
    • 0042322609 scopus 로고    scopus 로고
    • Persistence without pathology in phosphoglycan-deficient Leishmania major
    • Späth, G. F., L. F. Lye, H. Segawa, D. L. Sacks, S. J. Turco, and S. M. Beverley. 2003. Persistence without pathology in phosphoglycan-deficient Leishmania major. Science 301:1241-1243.
    • (2003) Science , vol.301 , pp. 1241-1243
    • Späth, G.F.1    Lye, L.F.2    Segawa, H.3    Sacks, D.L.4    Turco, S.J.5    Beverley, S.M.6
  • 10
    • 1542619246 scopus 로고    scopus 로고
    • Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response
    • Uzonna, J. E., G. F. Spath, S. M. Beverley, and P. Scott. 2004. Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response. J. Immunol. 172:3793-3797.
    • (2004) J. Immunol. , vol.172 , pp. 3793-3797
    • Uzonna, J.E.1    Spath, G.F.2    Beverley, S.M.3    Scott, P.4
  • 11
    • 0035893005 scopus 로고    scopus 로고
    • Immune elimination of Leishmania major in mice: Implications for immune memory, vaccination, and reactivation disease
    • Uzonna, J. E., G. Wei, D. Yurkowski, and P. Bretscher. 2001. Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease. J. Immunol. 167:6967-6974.
    • (2001) J. Immunol. , vol.167 , pp. 6967-6974
    • Uzonna, J.E.1    Wei, G.2    Yurkowski, D.3    Bretscher, P.4
  • 12
    • 0033536013 scopus 로고    scopus 로고
    • Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms
    • Walker, P. S., T. Scharton-Kersten, A. M. Krieg, L. Love-Homan, E. D. Rowton, M. C. Udey, and J. C. Vogel. 1999. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms. Proc. Natl. Acad. Sci. USA 96:6970-6975.
    • (1999) Proc. Natl. Acad. Sci. USA , vol.96 , pp. 6970-6975
    • Walker, P.S.1    Scharton-Kersten, T.2    Krieg, A.M.3    Love-Homan, L.4    Rowton, E.D.5    Udey, M.C.6    Vogel, J.C.7
  • 13
    • 7044254507 scopus 로고    scopus 로고
    • Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites
    • Zaph, C., J. Uzonna, S. M. Beverley, and P. Scott. 2004. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat. Med. 10:1104-1110.
    • (2004) Nat. Med. , vol.10 , pp. 1104-1110
    • Zaph, C.1    Uzonna, J.2    Beverley, S.M.3    Scott, P.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.